［1］CERSOSIMO F,LONARDI S,BERNARDINI G,et al.Tumor-associated macrophages in osteosarcoma:From mechanisms to therapy［J］.Int J Mol Sci,2020,21(15):5207.
［2］FERNANDES I,MELO-ALVIM C,LOPES-BRAS R,et al.Osteosarcoma pathogenesis leads the way to new target treatments［J］.Int J Mol Sci,2021,22(2):813.
［3］张丹,周逸驰.内质网应激相关基因能预测骨肉瘤预后并与肿瘤免疫微环境相关［J］.生物信息学,2023,21(4):247-262.
ZHANG D,ZHOU YC.Endoplasmic reticulum stress related genes can predict the prognosis of osteosarcoma patients and were correlated with tumor immune microenvironment［J］.Chinese Journal of Bioinformatics,2023,21(4):247-262.
［4］FAN TM.Animal models of osteosarcoma［J］.Expert Rev Anticancer Ther,2010,10(8):1327-1338.
［5］TSUKAMOTO S,ERRANI C,ANGELINI A,et al.Current treatment considerations for osteosarcoma metastatic at presentation［J］.Orthopedics,2020,43(5):e345-e358.
［6］TAN ML,CHOONG PF,DASS CR.Osteosarcoma:Conventional treatment vs gene therapy［J］.Cancer Biol Ther,2009,8(2):106-117.
［7］CORRE I,VERRECCHIA F,CRENN V,et al.The osteosarcoma microenvironment:A complex but targetable ecosystem［J］.Cells,2020,9(4):976.
［8］HARVEY KF,ZHANG X,THOMAS DM.The Hippo pathway and human cancer［J］.Nat Rev Cancer,2013,13(4):246-257.
［9］ZHU G,WANG Y,MIJITI M,et al.Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway［J］.Biochem Biophys Res Commun,2015,465(2):194-199.
［10］CHU C,ZHANG QC,DA ROCHA ST,et al.Systematic discovery of Xist RNA binding proteins［J］.Cell,2015,161(2):404-416.
［11］FERRE F,COLANTONI A,HELMER-CITTERICH M.Revealing protein-lncRNA interaction［J］.Brief Bioinform,2016,17(1):106-116.
［12］YI W,LI J,ZHU X,et al.CRISPR-assisted detection of RNA-protein interactions in living cells［J］.Nat Methods,2020,17(7):685-688.
［13］CHENG C,DING Q,ZHANG Z,et al.PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1［J］.J Cell Mol Med,2020,24(9):5274-5289.
［14］YAO XY,LIU JF,LUO Y,et al.LncRNA HOTTIP facilitates cell proliferation,invasion,and migration in osteosarcoma by interaction with PTBP1 to promote KHSRP level［J］.Cell Cycle,2021,20(3):283-297.
［15］LI JH,LIU S,ZHOU H,et al.starBase v2.0:Decoding miRNA-ceRNA,miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data［J］.Nucleic Acids Res,2014,42(Database issue):D92-97.
［16］LIVAK KJ,SCHMITTGEN TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2［-Delta Delta C(T)］method［J］.Methods,2001,25(4):402-408.
［17］吉新彦，钟国轩，赵斌.哺乳动物Hippo信号通路分子机制研究进展［J］.遗传，2017,39(7):546-567.
JI XY,ZHONG GX,ZHAO B.Molecular mechanisms of the mammalian Hippo signaling pathway［J］.Hereditas,2017,39(7):546-567.
［18］GUMBINER BM,KIM NG.The Hippo-YAP signaling pathway and contact inhibition of growth［J］.J Cell Sci,2014,127(Pt 4):709-717.
［19］BADOUEL C,MCNEILL H.SnapShot:The hippo signaling pathway［J］.Cell,2011,145(3):484.
［20］SHEN Y,XU J,PAN X,et al.LncRNA KCNQ1OT1 sponges miR-34c-5p to promote osteosarcoma growth via ALDOA enhanced aerobic glycolysis［J］.Cell Death Dis,2020,11(4):278.
［21］ZHAO D,WANG S,CHU X,et al.LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation,migration and invasion by regulating HIF2 expression［J］.Artif Cells Nanomed Biotechnol,2019,47(1):1342-1348.
［22］廖迎锋.lncRNA RHPN1-AS1靶向miR-485-5p调控骨肉瘤细胞增殖、凋亡、迁移、侵袭及其分子机制［J］.现代肿瘤医学，2021,29（20）：3544-3552.
LIAO YF.lncRNA RHPN1-AS1 regulates the proliferation,apoptosis,migration and invasion of osteosarcoma cells by targeting miR-485-5p and its molecular mechanism［J］.Modern Oncology,2021,29（20）：3544-3552.
［23］SONG N,KIM K,SHIN A,et al.Colorectal cancer susceptibility loci and influence on survival［J］.Genes Chromosomes Cancer,2018,57(12):630-637.
［24］SONG N,SHIN A,PARK JW,et al.Common risk variants for colorectal cancer:An evaluation of associations with age at cancer onset［J］.Sci Rep,2017,7:40644.
［25］ZHOU Y,JIN Q,XIAO W,et al.Tankyrase1 antisense oligodeoxynucleotides suppress the proliferation,migration and invasion through Hippo/YAP pathway in human osteosarcoma cells［J］.Pathol Res Pract,2019,215(6):152381.
［26］SU X,TENG J,JIN G,et al.ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2［J］.Biomed Pharmacother,2019,109:788-797.
［27］ZHANG J,MA X,ZHOU R,et al.TRPS1 and YAP1 regulate cell proliferation and drug resistance of osteosarcoma via competitively binding to the target of circTADA2A-miR-129-5p［J］.Onco Targets Ther,2020,13(12):397-407.
［28］GUIL S,ESTELLER M.Cis-acting noncoding RNAs:Friends and foes［J］.Nat Struct Mol Biol,2012,19(11):1068-1075.
［29］LIU Z,DAI J,SHEN H.Systematic analysis reveals long noncoding RNAs regulating neighboring transcription factors in human cancers［J］.Biochim Biophys Acta Mol Basis Dis,2018,1864(9 Pt B):2785-2792.
［30］CARRIERI C,CIMATTI L,BIAGIOLI M,et al.Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat［J］.Nature,2012,491(7424):454-457.